× Medicines Discovery Catapult

The Issue with Tissue

About 1 million patients have consented to their samples being used specifically in research studies. There are a further 3 to 5 million samples held in tissue banks in the UK, where patients have permitted their sample to be used in future studies. However, it has been estimated that only 15% of samples donated for research are ever used. […]

Read more

Webinar – Turning Molecules into Medicines

In this webinar, Gayle Marshall, Lead Scientist for Biomarkers, covers why drugs fail in the clinic and how to acquire critical information to inform confidence for clinical success. Gayle discusses how we can aid decision making from the pre-clinical to the clinical setting, supporting line of sight to the clinic, by identifying and translating crucial biomarker approaches […]

Read more

Use of health data by the life sciences industry: a UK perspective

This report explores the use of health data and the barriers faced by the UK life sciences industry. It highlights the tangible steps being taken by UK stakeholders to deliver a ‘clear, credible national offer’ for the R&D community, which would be in the public interest. It also highlights areas where further joint effort is needed for the UK to be globally competitive. The report was released in collaboration with the Association of […]

Read more

Webinar – Psychiatry Consortium first call for proposals

In this webinar Alessandra Gaeta, Programme Director, Syndicates, talks through the Psychiatry Consortium first call for proposals – including scope, eligibility and detail on the funding model. Recording Find out more about the Psychiatry Consortium >

Read more

Webinar – Imaging technologies to visualise drug discovery

Imaging allows a non-invasive assessment of biochemical and biological processes in a living subject. Monitoring, assessing, and characterising novel therapeutics in pre-clinical models is an essential part of drug development. In this webinar Dr Juliana Maynard, Lead Scientist in Pre-clinical Imaging, and Dr Philippa Hart, Lead Scientist in Mass Spectrometry Imaging, explore available imaging technologies […]

Read more

State of the Discovery Nation 2019

The 2019 edition of the State of the Discovery Nation report by the Medicines Discovery Catapult and the BIA reveals a thriving service and supply sector for the UK in addition to its R&D biotech’s. It also highlights two breakthrough technologies set to influence the future of medicines discovery and maintain the UK’s global competitiveness. Key […]

Read more

Webinar – State of the Discovery Nation 2019

In association with the BioIndustry Association (BIA), we have conducted our second review of the State of the Discovery Nation. This year, the report reviews the size and shape of the sector, and then focusses on two technology areas that are set to influence the future of Medicines Discovery: Complex (pre-clinical) cell models (CCMs) Artificial […]

Read more

Organ-on-a-chip Technologies (OOAC) – Current status and translatability of data

A joint report by Medicines Discovery Catapult, the Medical Research Council (MRC) Centre for Drug Safety Science (CDSS), based at the University of Liverpool, and the National Centre for the Replacement Refinement & Reduction of Animals in Research (NC3Rs) Experts from across academia, research, pharma, UK SMEs and the Medicines and Healthcare Products Regulatory Agency […]

Read more

Data Access Quick Guides

We have produced a series of Data Access Guides for a number of the major UK data suppliers that summarise the data they contain and how you might access it as an SME: Clinical Practice Research Datalink (CPRD) Provides real-world retrospective and prospective research services based on UK population electronic medical records NHS Digital Offers […]

Read more